Synthetic lethal metabolic targeting of cellular senescence in cancer therapy
The DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.
Abstract
Activated oncogenes and anticancer chemotherapy induce cellular senescence, a terminal growth arrest of viable cells characterized by S-phase entry-blocking histone 3 lysine 9 trimethylation (H3K9me3). Although therapy-induced senescence (TIS) improves long-term outcomes, potentially harmful properties of senescent tumour cells make their quantitative elimination a therapeutic priority. Here we use the Eµ-myc transgenic mouse lymphoma model in which TIS depends on the H3K9 histone methyltransferase Suv39h1 to show the mechanism and therapeutic exploitation of senescence-related metabolic reprogramming in vitro and in vivo. After senescence-inducing chemotherapy, TIS-competent lymphomas but not TIS-incompetent Suv39h1(-) lymphomas show increased glucose utilization and much higher ATP production. We demonstrate that this is linked to massive proteotoxic stress, which is a consequence of the senescence-associated secretory phenotype (SASP) described previously. SASP-producing TIS cells exhibited endoplasmic reticulum stress, an unfolded protein response (UPR), and increased ubiquitination, thereby targeting toxic proteins for autophagy in an acutely energy-consuming fashion. Accordingly, TIS lymphomas, unlike senescence models that lack a strong SASP response, were more sensitive to blocking glucose utilization or autophagy, which led to their selective elimination through caspase-12- and caspase-3-mediated endoplasmic-reticulum-related apoptosis. Consequently, pharmacological…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Another approach is based on the high lysosomal activity of some senescent cells that renders them sensitive to lysosomal ATPase inhibitors94.”
From Cellular senescence and senolytics: the path to the clinic (2022) · cites this paper as [94]
In the citing paper
“In preclinical models, proteotoxic stress not only drives entry into a senescent state, but also activates autophagy, which consequently buffers toxicity from misfolded SASP factors 44,45 .”
From Senescence and cancer — role and therapeutic opportunities (2022) · cites this paper as [45]
In the citing paper
“These findings suggest that mTOR inhibitors, commonly referred to as rapalogs, might induce or prevent senescence in a context- dependent manner 45,48,49 .”
From Senescence and cancer — role and therapeutic opportunities (2022) · cites this paper as [45]
In the citing paper
“Multiple factors involved in senescence induction, such as oxidative stress and proteotoxic stress, lead to protein misfolding, which in turn evokes endoplasmic reticulum stress via the unfolded protein response 45,53 .”
From Senescence and cancer — role and therapeutic opportunities (2022) · cites this paper as [45]
In the citing paper
“Reconversion of lactate to pyruvate by l-lactate dehydrogenase B fuels the TCA cycle out of the senescence-enforced enhancement of non-oxidative glucose metabolism (commonly referred to as the Warburg effect) 45 .”
From Senescence and cancer — role and therapeutic opportunities (2022) · cites this paper as [45]
16 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Subramanian, A., Tamayo, P., Mootha, V. K., Mukherjee, S., Ebert, B. L., Gillette, M. A., Paulovich, A., Pomeroy, S. L., Golub, T. R., Lander, E. S., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506580102 · Cited by 53,625
A biomarker that identifies senescent human cells in culture and in aging skin in vivo.
Dimri, G. P., Lee, X., Basile, G., Acosta, M., Scott, G., Roskelley, C., Medrano, E. E., Linskens, M., Rubelj, I., & Pereira-Smith, O. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.20.9363 · Cited by 7,477
Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a
Serrano, M., Lin, A. W., McCurrach, M. E., Beach, D., & Lowe, S. W. (1997) · Cell · doi:10.1016/s0092-8674(00)81902-9 · Cited by 5,218
Pankiv, S., Clausen, T. H., Lamark, T., Brech, A., Bruun, J.-A., Outzen, H., Øvervatn, A., Bjørkøy, G., & Johansen, T. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m702824200 · Cited by 4,578
Cellular senescence: when bad things happen to good cells
Campisi, J., & d'Adda di Fagagna, F. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2233 · Cited by 4,441
Autophagy and the Integrated Stress Response
Kroemer, G., Mariño, G., & Levine, B. (2010) · Molecular Cell · doi:10.1016/j.molcel.2010.09.023 · Cited by 3,506
Caspase-12 mediates endoplasmic-reticulum-specific apoptosis and cytotoxicity by amyloid-β
Nakagawa, T., Zhu, H., Morishima, N., Li, E., Xu, J., Yankner, B. A., & Yuan, J. (2000) · Nature · doi:10.1038/47513 · Cited by 3,256
Senescence and tumour clearance is triggered by p53 restoration in murine liver carcinomas
Xue, W., Zender, L., Miething, C., Dickins, R. A., Hernando, E., Krizhanovsky, V., Cordon-Cardo, C., & Lowe, S. W. (2007) · Nature · doi:10.1038/nature05529 · Cited by 2,473
Rb-mediated heterochromatin formation and silencing of E2F target genes during cellular senescence
Narita, M., Nuñez, S., Heard, E., Narita, M., Lin, A. W., Hearn, S. A., Spector, D. L., Hannon, G. J., & Lowe, S. W. (2003) · Cell · doi:10.1016/s0092-8674(03)00401-x · Cited by 2,278
Gas chromatography mass spectrometry–based metabolite profiling in plants
Lisec, J., Schauer, N., Kopka, J., Willmitzer, L., & Fernie, A. R. (2006) · Nature Protocols · doi:10.1038/nprot.2006.59 · Cited by 2,170
Self-citation
Cited by
Items 201–300 of 540
Senescent cells in cancer therapy: why and how to remove them
Zhang, J., Zhang, D., & Yu, B. (2021) · Cancer Letters · doi:10.1016/j.canlet.2021.07.002 · Cited by 59
Sadaie, M., Dillon, C., Narita, M., Young, A. R. J., Cairney, C. J., Godwin, L. S., Torrance, C. J., Bennett, D. C., Keith, W. N., & Narita, M. (2015) · Molecular Biology of the Cell · doi:10.1091/mbc.e15-01-0003 · Cited by 57
Nutrient sensing, growth and senescence
Carroll, B., & Korolchuk, V. I. (2018) · The FEBS Journal · doi:10.1111/febs.14400 · Cited by 50
Liu, P., Tang, Q., Chen, M., Chen, W., Lu, Y., Liu, Z., & He, Z. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.589908 · Cited by 54
Biphasic Modeling of Mitochondrial Metabolism Dysregulation during Aging
Baker, D. J., & Peleg, S. (2017) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2017.06.005 · Cited by 49
Mitochondrial metabolic reprogramming: An important player in liver cancer progression
Jin, T., Wang, C., Tian, Y., Dai, C., Zhu, Y., & Xu, F. (2019) · Cancer Letters · doi:10.1016/j.canlet.2019.11.029 · Cited by 53
Cancer Response to Therapy-Induced Senescence: A Matter of Dose and Timing
Mongiardi, M. P., Pellegrini, M., Pallini, R., Levi, A., & Falchetti, M. L. (2021) · Cancers · doi:10.3390/cancers13030484 · Cited by 53
Taschner‐Mandl, S., Schwarz, M., Blaha, J., Kauer, M. O., Kromp, F., Frank, N., Rifatbegovic, F., Weiss, T., Ladenstein, R. L., HOHENEGGER, M., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.6527 · Cited by 49
Menicacci, B., Laurenzana, A., Chillà, A., Margheri, F., Peppicelli, S., Tanganelli, E., Fibbi, G., Giovannelli, L., Del Rosso, M., & Mocali, A. (2017) · The Journals of Gerontology: Series A · doi:10.1093/gerona/glw336 · Cited by 47
“cancer-promoting SASP, and at the same time maintaining the beneficial features of cell senescence (26,27).”
Deng, Z., Manz, D. H., Torti, S. V., & Torti, F. M. (2019) · Antioxidants & Redox Signaling · doi:10.1089/ars.2017.7023 · Cited by 47
“2), as well as ER stress (18, 60).”
L’Hôte, V., Courbeyrette, R., Pinna, G., Cintrat, J., Le Pavec, G., Delaunay‐Moisan, A., Mann, C., & Thuret, J. (2021) · Aging Cell · doi:10.1111/acel.13447 · Cited by 37
“In conclusion, by deciphering the mechanisms of senolysis by cardioglycosides, and as previously shown in TIS (Dörr et al., 2013), we have identified autophagy as an essential process for the survival of BRAFsenescent cells.”
BackgroundMethodInfluentialGao, S., Sun, H., Jiang, H., Li, L., Hu, X., Xu, X., & Jin, W. (2015) · Oncotarget · doi:10.18632/oncotarget.6222 · Cited by 47
“Emerging evidence indicates that glucose metabolism also shifts in senescent cells [25-27].”
BackgroundMissios, P., Zhou, Y., Guachalla, L. M., von Figura, G., Wegner, A., Chakkarappan, S. R., Binz, T., Gompf, A., Hartleben, G., Burkhalter, M. D., et al. (2014) · Nature Communications · doi:10.1038/ncomms5924 · Cited by 46
Pathogenesis and therapeutic targeting of aberrant MYC expression in haematological cancers
Schick, M., Habringer, S., Nilsson, J. A., & Keller, U. B. (2017) · British Journal of Haematology · doi:10.1111/bjh.14917 · Cited by 47
Self-citationPietzke, M., Zasada, C., Mudrich, S., & Kempa, S. (2014) · Cancer & Metabolism · doi:10.1186/2049-3002-2-9 · Cited by 45
“The functionality of this concept was demonstrated by decoding the metabolic basis of synthetic lethality induced by metabolic inhibition of senescent lymphoma cells [38] and in MYC-driven cancer cells after ARK5 inhibition [18].”
BackgroundSelf-citationDeregulated transcription factors in the emerging cancer hallmarks
Hasan, A., Khan, N. A., Shahab Uddin, M. S., Khan, A. Q., & Steinhoff, M. S. (2023) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2023.12.001 · Cited by 48
Oxidative stress-induced senescence markedly increases disc cell bioenergetics
Patil, P. R., Falabella, M., Saeed, A., Lee, D., Kaufman, B. A., Shiva, S., Croix, C. M. S., Houten, B. V., Niedernhofer, L. J., Robbins, P. D., et al. (2019) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2019.04.006 · Cited by 46
Murray, D. L., & Mirzayans, R. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21165766 · Cited by 44
Keeping zombies alive: The ER-mitochondria Ca2+ transfer in cellular senescence
Ahumada-Castro, U., Puebla-Huerta, A., Cuevas-Espinoza, V., Lovy, A., & Cárdenas, C. (2021) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2021.119099 · Cited by 47
Metabolic alterations accompanying oncogene-induced senescence
Aird, K. M., & Zhang, R. (2014) · Molecular & Cellular Oncology · doi:10.4161/23723548.2014.963481 · Cited by 39
“Interestingly, a recent study found that exploiting metabolic changes during therapy-induced senescence of cancer cells could induce a synthetic lethality.(38) This suggests that these changes can be targeted in cancer patients to improve cancer therapy.”
BackgroundPasillas, M. P., Shields, S., Reilly, R., Strnadel, J., Behl, C., Park, R., Yates, J. R., Klemke, R., Gonias, S. L., & Coppinger, J. A. (2015) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m114.037697 · Cited by 42
“A recent study demonstrated that pharmacologically targeting the metabolic pathways of TIS in vivo prompted tumor regression and improved treatment outcomes (3).”
BackgroundPérès, E. A., Gérault, A. N., Valable, S., Roussel, S., Toutain, J., Divoux, D., Guillamo, J., Sanson, M., Bernaudin, M., & Petit, E. (2014) · Oncotarget · doi:10.18632/oncotarget.2937 · Cited by 44
Kunimasa, K., Nagano, T., Shimono, Y., Dokuni, R., Kiriu, T., Tokunaga, S., Tamura, D., Yamamoto, M., TACHIHARA, M. Y., Kobayashi, K., et al. (2017) · Cancer Science · doi:10.1111/cas.13266 · Cited by 44
Luo, Y., Fan, C., Yang, M., Dong, M., Bucala, R., Pei, Z., Zhang, Y., & Ren, J. T. (2020) · British Journal of Pharmacology · doi:10.1111/bph.14959 · Cited by 42
“SUV39H, a histone lysine methyltransferase and a hallmark for mammalian heterochromatin, was reported to participate in the regulation of autophagy in tumorigenesis, although little is known about this action in the heart (Dorr et al., 2013).”
BackgroundSreekumar, P. G., Reddy, S. T., Hinton, D. R., & Kannan, R. (2022) · Experimental Eye Research · doi:10.1016/j.exer.2021.108918 · Cited by 46
Payea, M. J., Dar, S. A., Anerillas, C., Martindale, J. L., Belair, C., Munk, R. B., Malla, S., Fan, J., Piao, Y., Yang, X., et al. (2024) · Molecular Cell · doi:10.1016/j.molcel.2024.10.003 · Cited by 48
Immunometabolism and oxidative stress: roles and therapeutic strategies in cancer and aging
Zhou, N.-J., Bao, W.-Q., Zhang, C., Jiang, M., Liang, T.-L., Ma, G.-Y., Liu, L., Pan, H., & Li, R.-Z. (2025) · npj Aging · doi:10.1038/s41514-025-00250-z · Cited by 50
“Additionally, metabolic reprogramming and oxidative stressform a positivefeedback loop: enhancedglycolysisin senescent cells increases mitochondrial ROS accumulation 106,107 , while cancer cells sustainhigh ROSlevelsviatheWarburg effect, promoting proliferationand inhibiting apoptosis 108 .”
Pathways from senescence to melanoma: focus on MITF sumoylation
Leclerc, J., Ballotti, R., & Bertolotto, C. (2017) · Oncogene · doi:10.1038/onc.2017.292 · Cited by 46
Senescence Inducer Shikonin ROS-Dependently Suppressed Lung Cancer Progression
Zheng, H., Huang, Q., Huang, S., Yang, X., Zhu, T., Wang, W., Wang, H., He, S., Ji, L., Wang, Y., et al. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.00519 · Cited by 40
“Due to intrinsic and primary physiological response against tumorigenesis, senescence-targeting approach were estimated to cause fewer feedback signaling alterations (Dörr et al., 2013) compared to other targeted chemotherapeutic agents such as gefitinib, afatinib, and cetuximab (Fertig et al.”
BackgroundUceda-Castro, R., Margarido, A. S., Cornet, L., Vegna, S., Hahn, K., Song, J., Putavet, D. A., van Geldorp, M., Çitirikkaya, C. H., de Keizer, P. L. J., et al. (2022) · Cell Reports Medicine · doi:10.1016/j.xcrm.2022.100821 · Cited by 43
“For instance, inducing senescence has been shown to increase overall survival in lymphoma,(30) and can be combined with glucose blockade to specifically eliminate senescent cells.(69) Similarly in liver cancer, the induction of senescence combined with administration of senolytic agents can significantly reduce tumor…”
Germain, D. (2016) · Advances in cancer research · doi:10.1016/bs.acr.2016.01.004 · Cited by 38
Autophagy Governs Protumorigenic Effects of Mitotic Slippage–induced Senescence
Jakhar, R., Luijten, M., Wong, A. X. F., Cheng, B., Guo, K., Neo, S. P., Au, B. V., Kulkarni, M., Lim, K. J., Maimaiti, J., et al. (2018) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-18-0024 · Cited by 39
“Using a mouse model of B-cell lymphoma treated with the DNA-damaging agent cyclophosphamide, the Schmitt and colleagues' group (36) recently reported that senescent cells rely on autophagy to cope with SASP-coupled proteotoxic stress.”
BackgroundMitochondrial Bioenergetics and Dynamics in Secretion Processes
Martínez, J., Marmisolle, I., Tarallo, D., & Quijano, C. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.00319 · Cited by 46
Cellular senescence signaling in cancer: A novel therapeutic target to combat human malignancies
Fakhri, S., Moradi, S. Z., DeLiberto, L. K., & Bishayee, A. (2022) · Biochemical Pharmacology · doi:10.1016/j.bcp.2022.114989 · Cited by 42
Resisting resistance: is there a solution for malaria?
Verlinden, B. K., Louw, A. I., & Birkholtz, L. (2016) · Expert Opinion on Drug Discovery · doi:10.1517/17460441.2016.1154037 · Cited by 44
“been successfully applied in the field of cancer therapeutics, [103,104] and has been investigated as a means to discover new antibiotic combination partners.”
BackgroundWang, A., Yang, F., Tian, Y., Su, J.-H., Gu, Q., Chen, W., Gong, S.-X., Ma, X., Qin, X.-P., & Jiang, Z. (2021) · Frontiers in Physiology · doi:10.3389/fphys.2021.656139 · Cited by 49
Malavolta, M., Costarelli, L., Giacconi, R., Basso, A., Piacenza, F., Pierpaoli, E., Provinciali, M., Ogo, O. A., & Ford, D. (2017) · Experimental Gerontology · doi:10.1016/j.exger.2017.09.006 · Cited by 37
“…intracellular labile Zn is an important element of the cellular stress response, cellular metabolic activity and synthesis of proteins (Beyersmann and Haase, 2001), the changes observed may reflect increased proteotoxic stress as a consequence of the SASP (Coppé et al., 2010; Dörr et al., 2013).”
Aging tumour cells to cure cancer: “pro-senescence” therapy for cancer
Calcinotto, A., & Alimonti, A. (2017) · Swiss Medical Weekly · doi:10.57187/smw.2017.14367 · Cited by 45
Cellular Senescence in Immunity against Infections
Marrella, V., Facoetti, A., & Cassani, B. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms231911845 · Cited by 45
“Senescent cells are “hypermetabolic”, and this metabolic reprogramming may potentially be therapeutically targetable [233], though it remains unclear how metabolismtargeted drugs can achieve sufficient specificity for senescent over non-senescent cells to allow clinical translation.”
BackgroundOverexpression of KLF4 promotes cell senescence through microRNA-203-survivin-p21 pathway
Xu, Q., Liu, M., Zhang, J., Xue, L., Zhang, G., Hu, C., Wang, Z., He, S., Chen, L., Ma, K., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.11200 · Cited by 40
“We also detected the senescence related proteins by Western Blot, and found that p21WAF1/CIP1 protein was strongly accumulated after KLF4 overexpression, accompanied by reduced expression of Cyclin E1 and increased expression of Suv39H1 [26], but no significant variation of p53 and p16Ink4a (Figure 1H).”
BackgroundHong, X., Wang, L., Zhang, K., Liu, J., & Liu, J. (2022) · Cells · doi:10.3390/cells11050877 · Cited by 38
Ketkar, M., Desai, S., Rana, P., Thorat, R. A., Epari, S., Dutt, A., & Dutt, S. (2024) · Neuro-Oncology · doi:10.1093/neuonc/noae134 · Cited by 43
Malavolta, M., Costarelli, L., Giacconi, R., Piacenza, F., Basso, A., Pierpaoli, E., Marchegiani, F., Cardelli, M., Provinciali, M., & Mocchegiani, E. (2014) · Nutrition Research · doi:10.1016/j.nutres.2014.02.006 · Cited by 37
“[43] Dörr JR, Yu Y, Milanovic M, Beuster G, Zasada C, Däbritz JH, et al.”
BackgroundThe Biology of Aging and Lymphoma: a Complex Interplay
Sarkozy, C., Salles, G. A., & Falandry, C. (2015) · Current Oncology Reports · doi:10.1007/s11912-015-0457-x · Cited by 37
Mamun, A. A., Sufian, M. A., Uddin, M. S., Sumsuzzman, D. M., Jeandet, P., Islam, M. S., Zhang, H., Kong, A. T., & Sarwar, M. S. (2022) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2022.174991 · Cited by 40
Disruptive chemicals, senescence and immortality
Carnero, A., Blanco-Aparicio, C., Kondoh, H., Lleonart, M. E., Martinez-Leal, J. F., Mondello, C., Scovassi, A. I., Bisson, W. H., Amedei, A., Roy, R., et al. (2015) · Carcinogenesis · doi:10.1093/carcin/bgv029 · Cited by 29
Blute, M. L., Damaschke, N., Wagner, J. L., Yang, B., Gleave, M. E., Fazli, L., Shi, F., Abel, E. J., Downs, T. M., Huang, W., et al. (2017) · PLoS ONE · doi:10.1371/journal.pone.0172048 · Cited by 36
H3K9me3-mediated epigenetic regulation of senescence in mice predicts outcome of lymphoma patients
Schleich, K., Kase, J., Dörr, J. R., Trescher, S., Bhattacharya, A., Yu, Y., Wailes, E. M., Fan, D. N. Y., Lohneis, P., Milanovic, M., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-17467-z · Cited by 32
Self-citationEffects of cellular senescence on metabolic pathways in non-immune and immune cells
Frasca, D., Saada, Y. B., Garcia, D., & Friguet, B. (2020) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2020.111428 · Cited by 36
“Moreover, metabolic differences between senescent and non-senescent cells have already been proven useful for the targeting of the upregulated pathways in senescent cells to promote their elimination as previously reported for the removal of chemotherapy induced senescent tumor cells by using synthetic lethal metaboli…”
BackgroundCD20-Targeting Immunotherapy Promotes Cellular Senescence in B-Cell Lymphoma
Däbritz, J. H. M., Yu, Y., Milanovic, M., Schönlein, M., Rosenfeldt, M. T., Dörr, J. R., Kaufmann, A. M., Dörken, B., & Schmitt, C. A. (2016) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-15-0627 · Cited by 37
“Importantly, RTX-induced senescence does not seem to primarily damage DNA, as other non-genotoxic stimuli have been shown to produce cellular senescence (16, 20, 45).”
BackgroundSelf-citationSenescence in cancer: Advances in detection and treatment modalities
Billimoria, R., & Bhatt, P. (2023) · Biochemical Pharmacology · doi:10.1016/j.bcp.2023.115739 · Cited by 38
Synthetic lethal approaches for assessing combinatorial efficacy of chemotherapeutic drugs
Jackson, R. A., & Chen, E. S. (2016) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2016.01.014 · Cited by 44
Shen, S., Mao, C.-Q., Yang, X., Du, X., Liu, Y., Zhu, Y., & Wang, J. (2014) · Molecular Pharmaceutics · doi:10.1021/mp400714z · Cited by 39
Cellular senescence and failure of myelin repair in multiple sclerosis
Koutsoudaki, P. N., Papadopoulos, D., Passias, P.-G., Koutsoudaki, P., & Gorgoulis, V. G. (2020) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2020.111366 · Cited by 33
Fernández-Duran, I., Quintanilla, A., Tarrats, N., Birch, J., Hari, P., Millar, F. R., Lagnado, A. B., Smer-Barreto, V., Muir, M., Brunton, V. G., et al. (2021) · Cell Death and Differentiation · doi:10.1038/s41418-021-00917-6 · Cited by 39
Huna, A., Salmiņa, K., Erenpreisa, J. A., Vázquez‐Martín, A., Krigerts, J., Inashkina, I., Gerashchenko, B. I., Townsend, P. A., Cragg, M. S., & Jackson, T. (2015) · Cell Cycle · doi:10.1080/15384101.2015.1056948 · Cited by 34
Transcriptomic Analysis of Cellular Senescence: One Step Closer to Senescence Atlas
Kim, S., & Kim, C. (2021) · Molecules and Cells · doi:10.14348/molcells.2021.2239 · Cited by 33
“Senescent cells are secretory cells that are still metabolically active, although their cell cycle is stably stopped (Dörr et al., 2013).”
BackgroundBöck, B. C., Stein, U., Schmitt, C. A., & Augustin, H. G. (2014) · Cancer Research · doi:10.1158/0008-5472.can-14-1424 · Cited by 33
“Clemens Schmitt (Charit e &MDC, Berlin, Germany) reported that senescent lymphoma cells have an extremely high energy demand and heavily rely on glucose (15).”
BackgroundSelf-citationTranslating the effects of mTOR on secretory senescence
Tomimatsu, K., & Narita, M. (2015) · Nature Cell Biology · doi:10.1038/ncb3244 · Cited by 39
Yu, Y., Yao, Y., Yan, H., Wang, R., Zhang, Z., Sun, X., Zhao, L., Ao, X., Xie, Z., & Wu, Q. (2016) · Molecular Therapy - Nucleic Acids · doi:10.1038/mtna.2016.28 · Cited by 31
Self-citationGrézy, A., Chevillard, M., Trouche, D., & Escaffit, F. (2015) · Molecular Biology of the Cell · doi:10.1091/mbc.e15-05-0316 · Cited by 39
“Of interest, sensitivity to therapy-induced senescence, which is a promising strategy for cancer treatment, is clearly linked to Suv39H1 expression (Dorr et al., 2013).”
BackgroundTranslating Mechanism-Based Strategies to Break the Obesity−Cancer Link: A Narrative Review
Smith, L. A., O’Flanagan, C. H., Bowers, L. W., Allott, E. H., & Hursting, S. D. (2017) · Journal of the Academy of Nutrition and Dietetics · doi:10.1016/j.jand.2017.08.112 · Cited by 37
Martínez, J., Tarallo, D., Palma, L. M., Victoria, S., Bresque, M., Rodríguez-Bottero, S., Marmisolle, I., Escande, C., Cassina, P., Casanova, G., et al. (2019) · Biochemical Journal · doi:10.1042/bcj20190405 · Cited by 36
Multiparameter flow cytometric detection and quantification of senescent cells in vitro
Adewoye, A. B., Tampakis, D., Follenzi, A., & Stolzing, A. (2020) · Biogerontology · doi:10.1007/s10522-020-09893-9 · Cited by 33
Sun, J., Li, G., Liu, Y., Ma, M., Song, K., Li, H., Zhu, D., Tang, X., Kong, J., & Yuan, X. (2019) · Neoplasia · doi:10.1016/j.neo.2019.10.006 · Cited by 32
“Studies demonstrated mitochondriaspecific oxidative features as a specific vulnerability of cells exhibiting therapy selective quiescence (TSQ), which when exploited, should be amendable to established cytotoxic interventions and provide the basis for developing more effective therapies to combat lethal disease [7,8].”
BackgroundPromises and challenges of senolytics in skin regeneration, pathology and ageing
Pils, V., Ring, N., Valdivieso, K., Lämmermann, I., Грубер, Ф., Schosserer, M., Grillari, J., & Ogrodnik, M. B. (2021) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2021.111588 · Cited by 34
Targeting Senescence as a Therapeutic Opportunity for Triple-Negative Breast Cancer
de Paula, B., Kieran, R., Koh, S. S. Y., Crocamo, S., Abdelhay, E. S. F. W., & Muñoz‐Espín, D. (2023) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-22-0643 · Cited by 36
“Therefore, targeting lysosomal ATPases has been shown in vitro and in vivo to lead to caspase-12- and caspase-3-mediated endoplasmic-reticulum-related apoptosis and, therefore, elimination of senescent cells by exploiting this metabolic vulnerability (24).”
BackgroundThe Power Behind the Throne: Senescence and the Hallmarks of Cancer
Hoare, M., & Narita, M. (2017) · Annual Review of Cancer Biology · doi:10.1146/annurev-cancerbio-030617-050352 · Cited by 33
Is cellular senescence involved in cystic fibrosis?
Bezzerri, V., Piacenza, F., Caporelli, N., Malavolta, M., Provinciali, M., & Cipolli, M. (2019) · Respiratory Research · doi:10.1186/s12931-019-0993-2 · Cited by 34
Valerio, H. P., Ravagnani, F. G., Ronsein, G. E., & Mascio, P. D. (2021) · Scientific Reports · doi:10.1038/s41598-021-02658-5 · Cited by 38
Yao, G., Yang, J., Li, X., Song, X., Hayashi, T., Tashiro, S., Onodera, S., Song, S., & Ikejima, T. (2017) · Acta Pharmacologica Sinica · doi:10.1038/aps.2017.39 · Cited by 33
Li, Z., Wang, J., Deng, X., Huang, D., Shao, Z., & Ma, K. (2020) · Connective Tissue Research · doi:10.1080/03008207.2020.1736578 · Cited by 31
Regulation of autophagy by bile acids and in cholestasis - CholestoPHAGY or CholeSTOPagy
Panzitt, K., Fickert, P., & Wagner, M. (2020) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2020.166017 · Cited by 33
Carpintero-Fernández, P., Borghesan, M., Eleftheriadou, O., Pan‐Castillo, B., Fafián‐Labora, J., Mitchell, T. P., Yuste, A., Öğrünç, M., Nightingale, T. D., Mayán, M. D., et al. (2022) · Cell Death and Disease · doi:10.1038/s41419-022-04569-3 · Cited by 32
Significant position of C-myc in colorectal cancer: a promising therapeutic target
Tan, L. H., Peng, D., & Cheng, Y. (2022) · Clinical & Translational Oncology · doi:10.1007/s12094-022-02910-y · Cited by 34
“Currently, in addition to glycolysis, mitochondrial metabolism also participates in the pathogenesis of cancer in multiple dimensions, such as proliferation [109, 110], metastatic dissemination [111, 112] and chemoresistance [113].”
BackgroundLipid metabolism dynamics in cancer stem cells: potential targets for cancers
Du, J., & Qin, H. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1367981 · Cited by 33
Yao, G., Yang, J., Li, Q., Zhang, Y., Qi, M., Fan, S., Hayashi, T., Tashiro, S., Onodera, S., & Ikejima, T. (2016) · Acta Pharmacologica Sinica · doi:10.1038/aps.2016.8 · Cited by 31
Toro, N. D., Ruiz, A. F., Mignacca, L., Kalegari, P., Rowell, M., Igelmann, S., Saint‐Germain, E., Benfdil, M., Lopes‐Paciencia, S., Brakier‐Gingras, L., et al. (2019) · Cell Cycle · doi:10.1080/15384101.2019.1593708 · Cited by 34
“Senescent cells are characterized as nonproliferative with a high rate of proteins synthesis and defects in ribosome biogenesis [16,30,31].”
BackgroundWang, S., Ma, K., Zhou, C., Wang, Y., Hu, G., Chen, L., Li, Z., Hu, C., Xu, Q., Zhu, H., et al. (2019) · Therapeutic Advances in Medical Oncology · doi:10.1177/1758835919843736 · Cited by 33
Transposons: Unexpected players in cancer
Pradhan, R. K., & Ramakrishna, W. (2021) · Gene · doi:10.1016/j.gene.2021.145975 · Cited by 35
Song, X.-H., Yang, L., Zheng, X., Zhu, Q., Liao, X.-L., Liu, K., Zhang, W., Peng, Q., Zhu, Y., Zhao, L.-Y., et al. (2023) · MedComm · doi:10.1002/mco2.342 · Cited by 32
Cholesterol biosynthetic pathway induces cellular senescence through ERRα
Ziegler, D. V., Czarnecka‐Herok, J., Vernier, M., Scholtes, C., Camprubi, C., Huna, A., Massemin, A., Griveau, A., Machon, C., Guitton, J., et al. (2024) · npj Aging · doi:10.1038/s41514-023-00128-y · Cited by 35
“Senescent cells harbour metabolic changes related to both catabolism and anabolism 1,10 – 15 , to the point that some metabolic speci fi cities of senescent cells are used to target or detect them 11,16,17 .”
BackgroundCell senescence: basic mechanisms and the need for computational networks in vascular ageing
Regnault, V., Challande, P., Pinet, F., Li, Z., & Lacolley, P. J. (2020) · Cardiovascular Research · doi:10.1093/cvr/cvaa318 · Cited by 28
Nagineni, C. N., Naz, S., Choudhuri, R., Chandramouli, G. V. R., Krishna, M. C., Brender, J., Cook, J. A., & Mitchell, J. B. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22094835 · Cited by 28
“After senescence-inducing chemotherapy, therapy-induced senescence (TIS) -competent lymphomas, but not TIS-incompetent Suv39h1– lymphomas, show increased glucose utilization and much higher ATP production [54].”
BackgroundResultInfluentialFrom the divergence of senescent cell fates to mechanisms and selectivity of senolytic drugs
L’Hôte, V., Mann, C., & Thuret, J. (2022) · Open Biology · doi:10.1098/rsob.220171 · Cited by 31
“The blockade of autophagy flux with bafilomycin A1 led to senolysis [14].”
BackgroundRevolutionizing Diabetic Foot Ulcer Care: The Senotherapeutic Approach
Zhang, G., Samarawickrama, P. N., Gui, L., Ma, Y., Cao, M., Zhu, H., Li, W., Yang, H., Li, K., Yang, Y., et al. (2024) · Aging and Disease · doi:10.14336/ad.2024.0065 · Cited by 32
“…and XIAP [196] Phloretin Sodium/glucose cotransporters Inhibitor of sodium/glucose cotransporters, decrease glucose uptake and increase apoptosis [197] GL-V9 Autolysosome Alkalize the lysosome and elevate ROS levels, aggravating mitophagy deficiency to induce apoptosis [198] RSL3 GPX4 Reduce the…”
Hsieh, Y., Huang, H.-S., Leu, Y., Peng, K., Chang, C., & Chang, M. (2015) · Environmental Toxicology · doi:10.1002/tox.22170 · Cited by 32
Understanding cellular senescence: pathways involved, therapeutics and longevity aiding
Kumar, A., & Thirumurugan, K. (2023) · Cell Cycle · doi:10.1080/15384101.2023.2287929 · Cited by 31
“Senescent cells are metabolically active even when they remain in the inactive stage of the cell cycle [76].”
BackgroundSuppression of autophagy induces senescence in the heart
Zhai, P., Sung, E., Shiheido‐Watanabe, Y., Takayama, K., Tian, Y., & Sadoshima, J. (2024) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2024.08.001 · Cited by 29
Kutyna, M., Kok, C. H., Lim, Y. P., Tran, E. N. H., Campbell, D., Paton, S., Thompson-Peach, C. A. L., Lim, K. S., Cakouros, D., Arthur, A., et al. (2022) · Leukemia · doi:10.1038/s41375-022-01686-y · Cited by 26
“In a transgenic Eμ-myc lymphoma model, senescence-inducing chemotherapy led to a hyper-catabolic phenotype with increased glycolysis and ATP production [44].”
BackgroundDrug-induced premature senescence model in human dental follicle stem cells
Zhai, Y., Wei, R., Liu, J., Wang, H., Cai, W., Zhao, M., Hu, Y., Wang, S., Yang, T., Liu, X., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.14085 · Cited by 26
“found that ageing is closely-related to profound metabolic balance [34, 35].”
BackgroundSu, Y., Wang, P., Shen, H., Sun, Z., Xu, C., Li, G., Tong, T., & Chen, J. (2018) · Journal of Cell Science · doi:10.1242/jcs.207217 · Cited by 24
“Consistent with previous results (Dörr et al., 2013), ER stress was induced, as demonstrated by increased phosphorylation of JNK1 (also known asMAPK8) (denoted p-JNK) and upregulation of the cyclic AMP-dependent transcription factor ATF4, and autophagy was activated, as indicated by the elevation of autophagy marker L…”
BackgroundResultInfluentialDynamic Metabolic Response to Adriamycin-Induced Senescence in Breast Cancer Cells
You, R., Dai, J., Zhang, P., Barding, G. A., & Raftery, D. (2018) · Metabolites · doi:10.3390/metabo8040095 · Cited by 24
“Higher utilization of glucose and higher ATP production were observed in therapy induced senescent (TIS)-competent lymphomas [10].”
BackgroundCellular senescence and frailty: a comprehensive insight into the causal links
Marcozzi, S., Bigossi, G., Giuliani, M. E., Giacconi, R., Piacenza, F., Cardelli, M., Brunetti, D., Segala, A., Valerio, A., Nisoli, E., et al. (2023) · GeroScience · doi:10.1007/s11357-023-00960-w · Cited by 28
“In murine xenograft, transplant, and spontaneous tumor models, both D + Q and several other senolyt-ics have shown that the removal of senescent cells can have preventive effects on tumor formation and relapse [110, 111, 132, 135, 152, 157–162].”
BackgroundThe interplay between cell death and senescence in cancer
Shimizu, K., Inuzuka, H., & Tokunaga, F. (2024) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2024.11.001 · Cited by 30
Remodeling of tumor microenvironment by cellular senescence and immunosenescence in cervical cancer
He, Y., Qiu, Y., Yang, X., Lu, G., & Zhao, S. (2024) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2024.11.002 · Cited by 25
Pyruvate Kinase M1 Suppresses Development and Progression of Prostate Adenocarcinoma
Davidson, S. M., Heyman, J. E., O’Brien, J. P., Liu, A. C., Schmidt, D. R., Israelsen, W. J., Dayton, T. L., Sehgal, R., Bronson, R. T., Freinkman, E., et al. (2022) · Cancer Research · doi:10.1158/0008-5472.can-21-2352 · Cited by 30
Time-resolved proteomic analyses of senescence highlight metabolic rewiring of mitochondria
Kim, J. Y., Atanassov, I., Dethloff, F., Kroczek, L., & Langer, T. (2023) · Life Science Alliance · doi:10.26508/lsa.202302127 · Cited by 25
Apoptotic transition of senescent cells accompanied with mitochondrial hyper-function
Wang, D., Liu, Y., Zhang, R., Zhang, F., Sui, W., Chen, L., Zheng, R., Chen, X., Wen, F., Ouyang, H., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.8536 · Cited by 28
“For example, senescent lymphoma cells induced by doxorubicin treatment display a highly glucose-consuming and energy-producing profile [8].”
Pantazi, A., Quintanilla, A., Hari, P., Tarrats, N., Parasyraki, E., Dix, F. L., Patel, J., Chandra, T., Acosta, J. C., & Finch, A. J. (2019) · Aging Cell · doi:10.1111/acel.12981 · Cited by 24
“cerevisiae, it resulted in an increase in translation accompanied by normal ribosome content, consistent with previous reports of senescence as a highly metabolically active process requiring elevated rates of translation (Dörr et al., 2013; Narita et al., 2011).”
Influential
Metadata
- Authors
- Dörr, J. R., Yu, Y., Milanovic, M., Beuster, G., Zasada, C., Däbritz, J. H. M., Lisec, J., Lenze, D., Gerhardt, A., Schleicher, K., Kratzat, S., Purfürst, B., Walenta, S., Mueller-Klieser, W., Gräler, M., Hummel, M., Keller, U., Buck, A. K., Dörken, B., Willmitzer, L., Reimann, M., Kempa, S., Lee, S., & Schmitt, C. A.
- Affiliations
- Charité – Universitätsmedizin Berlin (DE)
- Max Delbrück Center (DE)
- German Cancer Research Center (DE)
- Technical University of Munich (DE)
- Johannes Gutenberg University Mainz (DE)
- Jena University Hospital (DE)
- Universitätsklinikum Würzburg (DE)
- Max Planck Institute of Molecular Plant Physiology (DE)
- Corresponding author
- Schmitt, Clemens A.
- ORCID
- Venue
- Nature
- Published
- 2013-08-14
- Volume
- 501
- Issue
- 7467
- Pages
- 421-425
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W1987142903
- Cited by
- 541
- References
- 46
- Citations by year
- 2026: 24 · 2025: 35 · 2024: 42 · 2023: 42 · 2022: 40 · 2021: 55 · 2020: 57 · 2019: 35 · 2018: 45 · 2017: 37 · 2016: 43 · 2015: 41 · 2014: 44 · 2013: 1
- FWCI
- 29.86
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- MDC Repository (Max-Delbrueck-Center for Molecular Medicine) (submittedVersion)
- mediaTUM – the media and publications repository of the Technical University Munich (Technical University Munich) (submittedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Aging › Genetics, Aging, and Longevity in Model Organisms
- Keywords
- cellular senescence, therapy-induced senescence, synthetic lethality, metabolic targeting, glucose metabolism, autophagy inhibition, senescence-associated secretory phenotype, proteotoxic stress, endoplasmic reticulum stress, unfolded protein response, SUV39H1, H3K9 methylation, Eμ-Myc lymphoma, chemotherapy-induced senescence
- MeSH terms
- Animals, Autophagy, Disease Models, Animal, Female, Glucose, Male, Mice, Transgenic, Stress, Physiological, Survival Rate, Lymphoma, B-Cell, Cellular Senescence, Apoptosis, Mice, Caspase 3, Caspase 12, Proteolysis, Endoplasmic Reticulum Stress
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.